FDA Investigator David J Hafner

David J Hafner has inspections in 2 countries as of 27 Sep 2023. David J Hafner has collaborated with a combinined 4094 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
148
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada
Co-Investigator(s):
Alan D Centi, Albert A Salvador, Alicia M Mozzachio, Alla Kachko, PhD, Amy N Chen, Anastasia I Offordile, Anastasia M Shields, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Karnick, Ann Marie Montemurro, Ann Marie Schofield, Anna Marie Schofield, Anthony A Charity, Arlene M Badillo, Audrey Therese, Audrey Thereset Uy, Azza Talaat, Brandi L Garbutt, Brandon J Brookens, Brandy N Lepage, Brentley S Collins, Brian D Nicholson, Brian D Young, Brian S Keefer, Calvin W Edwards, Cara M Minelli, Carrie A Hughes, Caryn M Mcnab, CDR Jeremy L Wally, PhD, Cedar H Boakye, Chao Ming Tsai, Charanjeet Jassal, Charles R Cote, RIC, Charlotte E Wilkins, Christian D Lynch (CDL), Christina J Sauder, PhD, Christina K Theodorou, Christopher D Leach, Christopher J Adams, Colleen M Damon, Craig D Zagata, Crystal A Harlan, Cynthia Jim, CSO, Daniel R Tammariello, Daniel T Lee, Daniel W Johnson, Daryl A Dewoskin, Dave Hafner, David A Oluwo, David J Hapner, David L Pearce, Deborah G Haney Cozzone, Deborah H Cozzone, Deborah J Parris, Debra J Bennett, Debra L Pagano, Denise M Digiulio, Dennis Cantellops Paite, Deyaa Shaheen, Djamila Harouaka, Don Bark, PhD, Don H Bark, PhD, Dr. Gerald E Poly, Dr. Mark J Seaton, PhD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward D Mcdonald, Edwin L Hobbs, Edwin Melendez, Eileen A Liu, Elaine E Gilfillan, Ellen Huang, Erika M Wilkerson, Esther C Broner, PhD, Felix Maldonado, Gayle S Lawson, Gene D Arcy, George Pyramides, Gerald W Kopp, Hala L Selby, Harperd, Haruhiko Murata, Helen B Ricalde, J David Doleski, Jacob M Dyer, Jacqueline Mdiaz Albertini, Jacquelyn Gess, Jai P Singh, James C Maclaughlin, James L Dunnie, Jr, James M Mason, James P Mcevoy, James R Evans, Janet L Bowen, Javier E Santos, Javier O Vega, Jean Blackstone Hill, Jeen S Min, Jeffrey Harrison, Jessica L Pressley, Jessica S Estriplet, Joan A Loreng, Joan Adamo, Joanne M Hajoway, Jose Martinez, Jr, Joseph George, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Juanita P Versace, Julianne C Mccullough, Junho Pak, Karen A Briggs, Karen E D'orazio, Karyn M Campbell, Katelyn Astaub Zamperini, Kathleen B Mihalik, Kathryn Carbone, MD, Kelly N Kerr, Kendra L Brooks, Kenneth M Gordon, Kevin M Maguire, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kyle S Hobson, Latorie S Jones, LCDR Debra Emerson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Linda M Hoover, Linda Thai, Lisa B Orr, Lisa Feela, Lisa M Bellows, LT John M Mastalski, LTJG Bradley E Benasutti, Luis A Dasta, Marc A Jackson, Jr, Marcelo O Mangalindan, Jr, Marcus A Ray, Maria A Reed, Marian E Major, PhD, Marian E Ramirez, Marianela Aponte Cruz, Marie A Fadden, Marie M Fadden, Marsha W Major, Marsha W Nasur, Martha Sullivan Myrick, Matthew R Noonan, Maureen A Wentzel, Meyer J Slobotsky, Michael A Taylor, Michael Curbag, Michael D Omeara, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael R Klapal, Michele Gottshall, Michele M Falchek, Mihaly S Ligmond, Mindy M Chou, Nebil A Oumer, Nicholas L Paulin, Nikisha M Bolden, Omotunde O Osunsanmi, Paul L Bellamy, Paula A Trost, Prabhu P Raju, Qin Xu, Rabin N Ghoshal, Rachael O Oyewole, Raffi B Papazian, Ramon E Martinez, Rebecca K Olin, Regina T Brown, Robert B Shibuya, MD, Robert D Tollefsen, Robert G Ruff, Robert J Maffei, Robert J Martin, Robert Maffei, Robert W Jennings, Ronald A Stokes, Rose M Ashley, Russell J Glapion, Scott E Norris, Sean Y Kassim, PhD, Sena G Dissmeyer, Seng Ching Hwang, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Shelley L Waring, Shirley J Berryman, Shuang Tang, Simone E Pitts, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Steven D Kehoe, Steven E Kane, Susan F Laska, MS, Tajah L Blackburn, Tamil Arasu, PhD, Tammy L Chavis, Tekalign Wondimu, Terry Bridgewater, Thomas E Friel, Thomas J Arista, Tina M Pawlowski, Tina S Roecklein, Todd J Maushart, Tonya O Corbin, Travis R Hunt, Valerie G Vallely, Valerie L Whipp, Vlada Matusovsky, Wei Wang, PhD, William C Brenneman, William J Leonard, Xiao Wang, Yvins Dezan, Yvonne C Mcknight, Zhong Li, PhD, Zhongren Wu

David J Hafner's Documents

Publish Date Document Type Title
October, 2001 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2001-10-29
September, 2000 EIR Wyeth-Ayerst Pharmaceuticals, Inc - EIR, 2000-09-22
September, 2000 EIR Wyeth Division of Wyeth Pharmaceuticals, Inc. - EIR, 2000-09-21
January, 2001 EIR BAYER HEALTHCARE LLC - EIR, 2001-01-19
October, 2001 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2001-11-19
October, 2005 EIR Banta Packaging & Fulfillment, Inc. - EIR, 2005-10-18
April, 2001 FDA 483 Johnson & Johnson Merck Consumer Pharmaceuticals Company - Form 483, 2001-04-11
February, 2000 EIR Corixa Corporation - EIR, 2000-02-17
March, 2005 EIR BioSpectra Inc. - EIR, 2005-03-10
August, 2000 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2000-08-10
May, 2002 FDA 483 Response Sharp Packaging Services, LLC - Form 483R, 2002-05-30
September, 2003 EIR Scanlan Surgical, Llc - EIR, 2003-09-16
February, 2005 EIR Piramal Critical Care Inc - EIR, 2005-02-16
November, 2004 EIR Fisher Clinical Services Inc. - EIR, 2004-11-03
January, 2003 EIR Johnson & Johnson Consumer, Inc - EIR, 2003-01-10
June, 2000 FDA 483 Particle Size Technology Inc - Form 483, 2000-06-20
October, 2005 EIR The Jay Group, Inc. - EIR, 2005-10-18
August, 2005 EIR Medical Components, Inc dba MedComp - EIR, 2005-08-09
November, 2002 EIR BioSpectra Inc. - EIR, 2002-11-08
April, 2001 EIR Johnson & Johnson Consumer, Inc - EIR, 2001-04-11
February, 2000 FDA 483 Corixa Corporation - Form 483, 2000-02-17
November, 2003 EIR Hercon Pharmaceuticals LLC - EIR, 2003-11-05
October, 2001 EIR Merck Sharp & Dohme LLC - EIR, 2001-10-29
June, 2000 EIR Particle Size Technology Inc - EIR, 2000-06-20
April, 2003 EIR Novick Chemical Co Inc - EIR, 2003-04-22
February, 2000 FDA 483 Response Corixa Corporation - Form 483R, 2000-05-03
September, 2000 FDA 483 Hercon Pharmaceuticals LLC - Form 483, 2000-09-01
April, 2002 EIR DENTSPLY Pharmaceutical - EIR, 2002-04-09
May, 2002 FDA 483 Sharp Packaging Services, LLC - Form 483, 2002-05-24
February, 2003 FDA 483 Johnson Matthey Inc. - Form 483, 2003-02-14
June, 2000 FDA 483 Response Particle Size Technology Inc - Form 483R, 2000-06-26
June, 2001 FDA 483 Pharmaloz Manufacturing, Inc. - Form 483, 2001-06-20
May, 2002 EIR Sharp Packaging Services, LLC - EIR, 2002-05-24
December, 2003 EIR Sharp Packaging Services, LLC - EIR, 2003-12-22
October, 2003 EIR Exel, Inc. - EIR, 2003-10-02
November, 2003 EIR DENTSPLY Pharmaceutical - EIR, 2003-11-17
August, 2005 EIR SGS Chemical Solutions Laboratories Inc. - EIR, 2005-08-31
April, 2000 FDA 483 BAYER HEALTHCARE LLC - Form 483, 2000-04-25
September, 2000 FDA 483 Wyeth-Ayerst Pharmaceuticals, Inc - Form 483, 2000-09-22
December, 2003 EIR Dentsply Sirona Preventive - EIR, 2003-12-10
August, 2005 EIR Bio Med Sciences, Inc - EIR, 2005-08-10
August, 2000 EIR Merck Sharp & Dohme LLC - EIR, 2000-08-10
May, 2003 EIR Troy Manufacturing, Inc. - EIR, 2003-05-13
January, 2004 EIR Integra York PA, Inc - EIR, 2004-01-28
January, 2005 EIR Piramal Healthcare (Canada) Limited - EIR, 2005-01-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more